Performance of a commercial immunoglobulin M antibody capture assay using analyte-specific reagents to screen for interfering factors during a West Nile virus epidemic season in Nebraska

Anthony R. Sambol, Steven Heye Hinrichs, Wayne R. Hogrefe, Beth K. Schweitzer

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

In 2003, the Nebraska Public Health Laboratory tested more than 10,371 serum and 516 cerebral spinal fluid specimens. Results showed that without performing the interfering factors screen for specimens in the low positive index value range of >1.1 to ≤3.5, a false positivity rate of 6.5% would have been realized.

Original languageEnglish (US)
Pages (from-to)87-89
Number of pages3
JournalClinical and Vaccine Immunology
Volume14
Issue number1
DOIs
StatePublished - Jan 1 2007

Fingerprint

West Nile virus
Public health
Viruses
Immunoglobulin M
Assays
Public Health
Fluids
Antibodies
Serum

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Clinical Biochemistry
  • Microbiology (medical)

Cite this

@article{79b18e7c306841a384c343fe6f70887f,
title = "Performance of a commercial immunoglobulin M antibody capture assay using analyte-specific reagents to screen for interfering factors during a West Nile virus epidemic season in Nebraska",
abstract = "In 2003, the Nebraska Public Health Laboratory tested more than 10,371 serum and 516 cerebral spinal fluid specimens. Results showed that without performing the interfering factors screen for specimens in the low positive index value range of >1.1 to ≤3.5, a false positivity rate of 6.5{\%} would have been realized.",
author = "Sambol, {Anthony R.} and Hinrichs, {Steven Heye} and Hogrefe, {Wayne R.} and Schweitzer, {Beth K.}",
year = "2007",
month = "1",
day = "1",
doi = "10.1128/CVI.00272-06",
language = "English (US)",
volume = "14",
pages = "87--89",
journal = "Clinical and Vaccine Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "1",

}

TY - JOUR

T1 - Performance of a commercial immunoglobulin M antibody capture assay using analyte-specific reagents to screen for interfering factors during a West Nile virus epidemic season in Nebraska

AU - Sambol, Anthony R.

AU - Hinrichs, Steven Heye

AU - Hogrefe, Wayne R.

AU - Schweitzer, Beth K.

PY - 2007/1/1

Y1 - 2007/1/1

N2 - In 2003, the Nebraska Public Health Laboratory tested more than 10,371 serum and 516 cerebral spinal fluid specimens. Results showed that without performing the interfering factors screen for specimens in the low positive index value range of >1.1 to ≤3.5, a false positivity rate of 6.5% would have been realized.

AB - In 2003, the Nebraska Public Health Laboratory tested more than 10,371 serum and 516 cerebral spinal fluid specimens. Results showed that without performing the interfering factors screen for specimens in the low positive index value range of >1.1 to ≤3.5, a false positivity rate of 6.5% would have been realized.

UR - http://www.scopus.com/inward/record.url?scp=34247849528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247849528&partnerID=8YFLogxK

U2 - 10.1128/CVI.00272-06

DO - 10.1128/CVI.00272-06

M3 - Article

VL - 14

SP - 87

EP - 89

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

SN - 1556-6811

IS - 1

ER -